Naproxen Tablet
Product Images NDC 51655-657

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Naproxen (NDC 51655-657). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Label (51655 657 52 Master Bottle Label Approval Rev A 04 21)

Label (51655 657 52 Master Bottle Label Approval Rev A 04 21)
This is a description of Naproxen tablets, USP with a strength of 375 mg manufactured by ScieGen Pharmaceuticals Inc. The tablets come in a bottle of 30 tablets, and are only available with a prescription. The tablets should be stored at a temperature ranging from 20°C to 25°C, with excursions between 15°C and 30°C permitted. The tablets should be kept away from children and should be stored in the original container. Each tablet contains 375mg of naproxen. The repackaging was done by Northwind Pharmaceuticals based in Indianapolis, and the tablets are identified using a GTIN: 0351655657522. There are some manufacturing details provided such as Lot S/N: 000000000000000, EXP: 00/00/0000, and LOT: 0000000000.*
FDA Label Image

Structural Formula (Naproxentabs Str)

Structural Formula (Naproxentabs Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.